Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry.
Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Rattarittamrong E, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C. Chanswangphuwana C, et al. Among authors: limvorapitak w. Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):e915-e921. doi: 10.1016/j.clml.2022.06.005. Epub 2022 Jun 12. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35792033
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Limvorapitak W, Barnett MJ, Hogge DE, Forrest DL, Nevill TJ, Narayanan S, Power MM, Nantel SH, Broady R, Song KW, Toze CL, Mourad YA, Sutherland HJ, Gerrie AS, White J, Sanford DS. Limvorapitak W, et al. Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e481-e491. doi: 10.1016/j.clml.2018.07.290. Epub 2018 Jul 17. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30100330 Clinical Trial.
Improved Survival of Elderly-fit Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From TALWG.
Owattanapanich W, Utchariyaprasit E, Tantiworawit A, Rattarittamrong E, Niparuck P, Puavilai T, Julamanee J, Saelue P, Chanswangphuwana C, Polprasert C, Limvorapitak W, Kanitsap N, Wanitpongpun C, Nakhakes C, Sriswasdi C, Prayongratana K. Owattanapanich W, et al. Among authors: limvorapitak w. Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):e509-e514. doi: 10.1016/j.clml.2018.08.002. Epub 2018 Aug 8. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30213720
Better survivals in adolescent and Young adults, compared to adults with acute lymphoblastic leukemia - A multicenter prospective registry in Thai population.
Limvorapitak W, Owattanapanich W, Utchariyaprasit E, Niparuck P, Puavilai T, Tantiworawit A, Rattanathammethee T, Saengboon S, Sriswasdi C, Julamanee J, Saelue P, Polprasert C, Wudhikarn K, Wanitpongpun C, Prayongratana K; Thai Acute Leukemia Working Group. Limvorapitak W, et al. Leuk Res. 2019 Dec;87:106235. doi: 10.1016/j.leukres.2019.106235. Epub 2019 Oct 15. Leuk Res. 2019. PMID: 31675661
Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG).
Wanitpongpun C, Utchariyaprasit E, Owattanapanich W, Tantiworawit A, Rattarittamrong E, Niparuck P, Puavilai T, Julamanee J, Saelue P, Chanswangphuwana C, Polprasert C, Nakhakes C, Limvorapitak W, Kanitsap N, Prayongratana K, Sriswasdi C. Wanitpongpun C, et al. Among authors: limvorapitak w. Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):e635-e643. doi: 10.1016/j.clml.2021.03.004. Epub 2021 Mar 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33926829 Free article.
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Tantiworawit A, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C. Chanswangphuwana C, et al. Among authors: limvorapitak w. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):e1075-e1083. doi: 10.1016/j.clml.2022.08.010. Epub 2022 Aug 23. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36117042
External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival.
Warnnissorn N, Kanitsap N, Niparuck P, Boonsakan P, Kulalert P, Limvorapitak W, Bhoopat L, Saengboon S, Chantrathammachart P, Puavilai T, Chuncharunee S. Warnnissorn N, et al. Among authors: limvorapitak w. Hematology. 2022 Dec;27(1):1237-1245. doi: 10.1080/16078454.2022.2147916. Hematology. 2022. PMID: 36413354
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
Kungwankiattichai S, Owattanapanich W, Rattanathammethee T, Rattarittamrong E, Chanswangphuwana C, Polprasert C, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Prayongratana K, Sriswasdi C, Nakhakes C. Kungwankiattichai S, et al. Among authors: limvorapitak w. Hematology. 2023 Dec;28(1):2191462. doi: 10.1080/16078454.2023.2191462. Hematology. 2023. PMID: 36951362
23 results